Clinical trial
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial…
NCT00138242 · Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center, Other · Completed
Key facts
| NCT number | NCT00138242 |
|---|---|
| Title | Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer |
| Official title | Phase II Trial of Weekly Docetaxel (Taxotere®) and Carboplatin as Initial Chemotherapy for Women With Ovarian Cancer and Similar Malignancies |
| Lead sponsor | Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, docetaxel, adjuvant therapy |
| Enrollment | 30 |
| Start date | Dec 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Aug 30, 2005 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: